Ayr Wellness named Cannabis Top Pick for 2022 at Needham 09:32 AYRWF Needham analyst Matt McGinley named Ayr Wellness as the Top Pick for 2022 in the Cannabis space and also named the stock to Needham Conviction List. Ayr will have the highest revenue and EBITDA growth in 2022, but the stock trades at the lowest enterprise value to expected EBITDA multiple in the group, the analyst tells investors in a research note. There is some risk to revenue and EBITDA estimates related to timing and productivity ramps, but the multiple is low enough that it mitigates downside risk, McGinley adds, keeping his Buy rating and $35 price target on Ayr Wellness shares. ....... We'll have to watch these pot stks... looks like this analyst was thinking along my lines...
SNAP IS $1 off it's low the annoying thing is when you look up the name the news is all law firms suing.! Not a good look.
I'm glad I'm not the one making the decisions today! With all these Hints.... IMAX<------ But they have China trouble. Sony<-- But did they get enough PS 5's out?
Stoney I said that on Aug 30th. It went to $161 It was a 10% winner. Now it's pulled back. Boring is good. $140 is a great place to buy a few shares. If it goes lower, buy a few more. Solid solid company. PWR is down today too. Buy some of it at $104
But these aren't moving! You never make any money... I know that's a bad reason to sell. Maybe it's not a good IRA stock. EBAY VAN LETS TALK!
AVTR TRIPLE BOTTOM ALERT $38 ALERT***** Avantor, Inc. (AVTR) IS A BUY! NYSE - Nasdaq Real Time Price. Currency in USD 39.55-0.35 (-0.88%) As of 10:18AM EST. Market open.